✦ LIBER ✦

Phase 1 Clinical Trial of Re-irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Patients With Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck

✍ Scribed by Porosnicu, M.; Greven, K.M.; Sullivan, C.A.; Waltonen, J.D.; Rouchard, R. Plasser; Browne, J.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1/2 Clinical Trial of Re-irradiati

✍ Lucas, J.T.; Porosnicu, M.; Plasser, R.; Sullivan, C.A.; Waltonen, J.D.; Browne, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Erlotinib and bevacizumab in patients wi

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

Re-Irradiation With Stereotactic Body Ra

✍ Vargo, J.; Ferris, R.L.; Ohr, J.; Clump, D.A.; Davis, K.; Johnson, J.; Gibson, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase 2 Trial of Continuous Course Re-ir

✍ Yao, M.; Wang, D.; Sumer, B.D.; Larry, M.; Truelson, J.; Randall, H.; Wong, S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A Phase II Trial of Bryostatin-1 in Pati

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB

Randomized phase III trial (GORTEC 98-03

✍ Jacques Tortochaux; Yungan Tao; Elodie Tournay; Michel Lapeyre; Francois Lesauni 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 214 KB